BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Uterine cancer AND RB1, OSRC, ENSG00000139687, 5925, RB, P06400 AND Diagnosis
27 results:

  • 1.
    Flores Legarreta A; Salvo G; Gonzales NR; Chisholm G; Hillman RT; Frumovitz M
    J Gynecol Oncol; 2023 Jul; 34(4):e50. PubMed ID: 36807750
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Molecular-Based Immunohistochemical Algorithm for uterine Leiomyosarcoma diagnosis.
    Momeni-Boroujeni A; Yousefi E; Balakrishnan R; Riviere S; Kertowidjojo E; Hensley ML; Ladanyi M; Ellenson LH; Chiang S
    Mod Pathol; 2023 Apr; 36(4):100084. PubMed ID: 36788080
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. uterine Leiomyosarcoma Masquerading as a Malignant Perivascular Epithelioid Cell Tumor: A Diagnostic Challenge.
    Natsume T; Yoshida H; Nishikawa T; Kikkawa N; Naka T; Kobayashi-Kato M; Tanase Y; Uno M; Ishikawa M; Kato T
    Int J Surg Pathol; 2023 Aug; 31(5):778-784. PubMed ID: 36310451
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Driver gene mutations in micro-invasive cervical squamous cancers have no prognostic significance.
    Kashofer K; Regauer S; Reich O; Petru E; Winter E
    Gynecol Oncol; 2022 Apr; 165(1):121-128. PubMed ID: 35101299
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Morphological Based Medical Image Processing on Cervical Cytology cancer Images Using Connected Component Techniques.
    Robert P; Kavida AC
    Curr Med Imaging; 2021; 17(12):1439-1450. PubMed ID: 34238167
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Downregulation of 5-hydroxymethylcytosine is associated with the progression of cervical intraepithelial neoplasia.
    Kato M; Onoyama I; Kawakami M; Yoshida S; Kawamura K; Kodama K; Hori E; Cui L; Matsumura Y; Yagi H; Asanoma K; Yahata H; Itakura A; Takeda S; Kato K
    PLoS One; 2020; 15(11):e0241482. PubMed ID: 33141854
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Corded and Hyalinized Endometrioid Adenocarcinoma (CHEC) of the uterine Corpus are Characterized by CTNNB1 Mutations and Can Show Adverse Clinical Outcomes.
    Ladwig NR; Umetsu SE; Zaloudek C; Rabban J; Garg K
    Int J Gynecol Pathol; 2021 Mar; 40(2):103-115. PubMed ID: 32909971
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Genomic Profiling Aids Classification of Diagnostically Challenging uterine Mesenchymal Tumors With Myomelanocytic Differentiation.
    Selenica P; Conlon N; Gonzalez C; Frosina D; Jungbluth AA; Beets-Tan RGH; Rao MK; Zhang Y; Benayed R; Ladanyi M; Solit DB; Chiang S; Hyman DM; Hensley ML; Soslow RA; Weigelt B; Murali R
    Am J Surg Pathol; 2021 Jan; 45(1):77-92. PubMed ID: 32889887
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Recommendations for Long-Term Follow-up of Adults with Heritable Retinoblastoma.
    Tonorezos ES; Friedman DN; Barnea D; Bosscha MI; Chantada G; Dommering CJ; de Graaf P; Dunkel IJ; Fabius AWM; Francis JH; Greer MC; Kleinerman RA; Kors WA; Laughlin S; Moll AC; Morton LM; Temming P; Tucker MA; van Leeuwen FE; Walsh MF; Oeffinger KC; Abramson DH
    Ophthalmology; 2020 Nov; 127(11):1549-1557. PubMed ID: 32422154
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Genomic Landscape of uterine Sarcomas Defined Through Prospective Clinical Sequencing.
    Hensley ML; Chavan SS; Solit DB; Murali R; Soslow R; Chiang S; Jungbluth AA; Bandlamudi C; Srinivasan P; Tap WD; Rosenbaum E; Taylor BS; Donoghue MTA; Hyman DM
    Clin Cancer Res; 2020 Jul; 26(14):3881-3888. PubMed ID: 32299819
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Murine Oviductal High-Grade Serous Carcinomas Mirror the Genomic Alterations, Gene Expression Profiles, and Immune Microenvironment of Their Human Counterparts.
    McCool KW; Freeman ZT; Zhai Y; Wu R; Hu K; Liu CJ; Tomlins SA; Fearon ER; Magnuson B; Kuick R; Cho KR
    Cancer Res; 2020 Feb; 80(4):877-889. PubMed ID: 31806642
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Hysteroscopic Photodynamic diagnosis Using 5-Aminolevulinic Acid: A High-Sensitivity Diagnostic Method for uterine Endometrial Malignant Diseases.
    Matoba Y; Banno K; Kisu I; Kobayashi Y; Tsuji K; Nagai S; Yamagami W; Nakamura M; Tominaga E; Kawaida M; Aoki D
    J Minim Invasive Gynecol; 2020; 27(5):1087-1094. PubMed ID: 31415818
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Potential Diagnostic Pitfalls in Evaluating Immunohistochemistry for Cervical Myofibroblastomas.
    Song S; Ziober A; Cooper K
    Int J Gynecol Pathol; 2019 Nov; 38(6):597-601. PubMed ID: 30383612
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Molecular biomarkers for uterine leiomyosarcoma and endometrial stromal sarcoma.
    Tsuyoshi H; Yoshida Y
    Cancer Sci; 2018 Jun; 109(6):1743-1752. PubMed ID: 29660202
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Genome profiling is an efficient tool to avoid the STUMP classification of uterine smooth muscle lesions: a comprehensive array-genomic hybridization analysis of 77 tumors.
    Croce S; Ducoulombier A; Ribeiro A; Lesluyes T; Noel JC; Amant F; Guillou L; Stoeckle E; Devouassoux-Shisheboran M; Penel N; Floquet A; Arnould L; Guyon F; Mishellany F; Chakiba C; Cuppens T; Zikan M; Leroux A; Frouin E; Farre I; Genestie C; Valo I; MacGrogan G; Chibon F
    Mod Pathol; 2018 May; 31(5):816-828. PubMed ID: 29327710
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Does a p53 "Wild-type" Immunophenotype Exclude a diagnosis of Endometrial Serous Carcinoma?
    Fadare O; Roma AA; Parkash V; Zheng W; Walavalkar V
    Adv Anat Pathol; 2018 Jan; 25(1):61-70. PubMed ID: 28945609
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Putative biomarkers for cervical cancer: SNVs, methylation and expression profiles.
    Cardoso MFS; Castelletti CHM; Lima-Filho JL; Martins DBG; Teixeira JAC
    Mutat Res Rev Mutat Res; 2017 Jul; 773():161-173. PubMed ID: 28927526
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Downregulation of p16(ink4a) inhibits cell proliferation and induces G1 cell cycle arrest in cervical cancer cells.
    Zhang CY; Bao W; Wang LH
    Int J Mol Med; 2014 Jun; 33(6):1577-85. PubMed ID: 24714974
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. HPV and cervical cancer: updates on an established relationship.
    Subramanya D; Grivas PD
    Postgrad Med; 2008 Nov; 120(4):7-13. PubMed ID: 19020360
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Molecular approaches to cervical cancer therapy.
    Alvarez-Salas LM; DiPaolo JA
    Curr Drug Discov Technol; 2007 Oct; 4(3):208-19. PubMed ID: 17986003
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.